Stock listing

NASDAQ:AVEO AVEO Pharmaceuticals Inc Stock

Follow AVEO Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AVEO

$15.00 USD

Close on Jan 20, 2023 · No longer trades

Feb 20, 2020 to last close +185.7% · weekly closes, Feb 20, 2020 – Jan 20, 2023
Lowest – highest close
$2.60 – $15.28 USDSince Feb 20, 2020 · lowest Mar 18, 2020 · highest Mar 10, 2021

Delisted NASDAQ:AVEO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AVEO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

AVEO Pharmaceuticals Inc on 6ix

Calls
6 calls with a replay · 6 with a transcript · latest Aug 4, 2022
Decks
27 decks · latest Aug 9, 2022

Events

CallWhenStatus
AVEO Pharmaceuticals (AVEO) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
AVEO Pharmaceuticals (AVEO) Q1 2022 Earnings CallThu, May 05, 2022 · 8:30 AM ETReplay
AVEO Pharmaceuticals (AVEO) Q4 2021 Earnings CallMon, Mar 14, 2022 · 8:30 AM ETReplay
AVEO Pharmaceuticals (AVEO) Q3 2021 Earnings CallMon, Nov 08, 2021 · 4:30 PM ETReplay
AVEO Pharmaceuticals (AVEO) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
AVEO Pharmaceuticals (AVEO) Q1 2021 Earnings CallMon, May 10, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2022)Investor deck44 slidesAug 9, 2022
Investor Presentation (May 2022)Investor deck46 slidesMay 6, 2022
Investor Presentation (March 2022)Investor deck47 slidesMar 14, 2022
Investor Presentation (July 2021)Investor deck47 slidesJul 16, 2021
Investor Presentation (July 2020)Investor deck26 slidesJul 6, 2020
Corporate Update (May 2020)Corporate update25 slidesMay 29, 2020
Investor Presentation (November 2019)Investor deck36 slidesNov 5, 2019
Investor Presentation (October 2019)Investor deck34 slidesOct 3, 2019
Investor Presentation (September 2019)Investor deck31 slidesSep 10, 2019
Investor Presentation (February 2019)Investor deck34 slidesFeb 15, 2019
All 27 decks
DeckKindSlidesDate
Corporate Update (November 2018)Corporate update21 slidesNov 5, 2018
36th Annual JP Morgan Healthcare Conference (January 2018)Conference32 slidesJan 4, 2018
Investor Presentation (August 2017)Investor deck31 slidesAug 10, 2017
Investor Presentation (April 2017)Investor deck32 slidesApr 5, 2017
Investor Presentation (January 2017)Investor deck35 slidesJan 4, 2017
Investor Presentation (November 2016)Investor deck35 slidesNov 8, 2016
Investor Presentation (June 2016)Investor deck36 slidesJun 15, 2016
Investor Presentation (April 2016)Investor deck39 slidesApr 4, 2016
Investor Presentation (January 2016)Investor deck35 slidesJan 5, 2016
Investor Presentation (April 2015)Investor deck38 slidesApr 8, 2015
JP Morgan 2015 Global Healthcare ConferenceConference33 slidesJan 13, 2015
Investor Presentation (March 2014)Investor deck13 slidesMar 13, 2014
Investor Presentation (February 2013)Investor deck29 slidesFeb 27, 2013
Q4 2012 Earnings PresentationEarnings28 slidesFeb 13, 2013
31st Annual J.P. Morgan Healthcare Conference 2013Conference29 slidesJan 7, 2013
30th Annual J.P. Morgan Healthcare Conference (January 2012)Conference28 slidesJan 9, 2012
29th Annual JP Morgan Healthcare Conference (January 2011)Conference18 slidesJan 10, 2011

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John H. Johnson
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past)
Director · Feb 1, 2018 – Feb 1, 2018 · Past
Robert C Young
Other companies: Human Genome Sciences Inc (Director · May 17, 2012 – Jul 30, 2012 · Past); West Pharmaceutical Services, Inc. (Director · Sep 30, 2011 – Sep 30, 2011 · Past)
Director · May 30, 2012 – Jun 10, 2020 · Past
Michael P. Bailey
Other companies: Verastem, Inc. (Board Member · Since at least May 21, 2026)
President & CEO, Director · Jun 26, 2013 – Jan 19, 2023 · Past
Kevin Joseph CullenDirector · Apr 15, 2021 – Jan 19, 2023 · Past
Michael FerraressoChief Commercial Officer · Mar 10, 2021 – Jan 19, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about AVEO Pharmaceuticals Inc.